YOUR CONDITION, EXPLAINED
Benign Neoplasms of Endocrine System VA disability rating & claim guide
The VA rates Benign Neoplasms of Endocrine System under diagnostic code 7915, in 38 CFR § 4.119 (endocrine system), and that code carries no rating ladder of its own. The percentage comes from elsewhere in Part 4 rather than from tiers under this code.
Free · No account needed
Save your Benign Neoplasms of Endocrine System guide
Email yourself this Benign Neoplasms of Endocrine System guide so the rating criteria, evidence checklist, and preparation tips are easy to find later.
A CLEARER PATH FORWARD
Make sense of your next step.
01Understand the rating02Know what to gather03Plan your preparationTHE ESSENTIALS
How the VA rates Benign Neoplasms of Endocrine System
DC 7915 covers a benign — non-cancerous — neoplasm in any specified part of the endocrine system. The code states no percentages of its own; its whole entry is the instruction "Rate as residuals of endocrine dysfunction." So the evaluation comes from the endocrine dysfunction the growth leaves behind, not from the tumor's size or from the fact that it is benign. Where a neoplasm of the same system is malignant, the code is DC 7914 instead, which carries its own 100 percent evaluation.
There is no criteria table under DC 7915. The schedule's entire entry reads: "Rate as residuals of endocrine dysfunction." The percentage therefore comes from the dysfunction actually present and documented — each residual evaluated under the diagnostic code that covers it — rather than from anything about the neoplasm itself. That makes the hormonal picture, not the imaging finding, the substance of the claim: where no endocrine dysfunction is documented, this instruction has nothing to route.
- Diagnostic code
- 7915
- Rating schedule
- 38 CFR § 4.119
- Levels in this guide
- None under this code
BUILD YOUR EVIDENCE, ONE PIECE AT A TIME
Evidence for your Benign Neoplasms of Endocrine System claim
A long list feels easier when you have a place to start. Use this checklist to see what you have and what still needs gathering.
Check off what you’ve gathered. Progress stays on this page until you leave or refresh.
THE EXAM FORM
Which DBQ is used for Benign Neoplasms of Endocrine System?
VA publishes its questionnaires by body system; find the one for this condition on VA's list.
Source: VA: Public Disability Benefits Questionnaires (DBQs), read September 18, 2026.
SMALL DETAILS. BETTER PREPARATION.
Preparing your Benign Neoplasms of Endocrine System claim
Start with the practical tips, then explore the common oversights. You don’t need to work through everything at once.
Practical tips for your claim2 tips
- 01
Focus your evidence on the hormone impact specifically, not just the tumor's presence, since this rating is built around functional endocrine disruption rather than the growth itself.
- 02
Include lab trends over time, since a documented pattern of hormone imbalance is more persuasive than a single test result.
C&P exam pitfalls to keep in mind2 tips
- 01
Not proving an actual hormone disturbance, which is required beyond just confirming the tumor exists.
- 02
Assuming 'benign' means no functional impact, when hormone disruption can still be significant even with a non-cancerous growth.
Common filing mistakes2 tips
- 01
Submitting the claim without a hormone panel to establish the functional impact.
- 02
Missing documentation of the actual symptoms experienced, beyond the imaging finding alone.
When symptoms may first appear1 tips
- 01
Whether the neoplasm turns up incidentally on imaging or after symptoms prompt testing, DC 7915 does not evaluate its discovery. Its instruction routes the rating to residuals of endocrine dysfunction, so the record that carries the claim is the one documenting hormone function over time.
THE BROADER PICTURE
Benign Neoplasms of Endocrine System by the numbers
- Approval outlook
- Moderate when gland dysfunction is shown.
- Veterans service-connected
- ~1,300 veterans
Vetrify editorial estimates informed by VA published claims data (VBA Annual Benefits Report) and the VA rating schedule, not official VA statistics.
LET’S CLEAR A FEW THINGS UP
Common questions about Benign Neoplasms of Endocrine System
Is Benign Neoplasms of Endocrine System a VA-rated disability?
Yes. The VA rates Benign Neoplasms of Endocrine System under VASRD diagnostic code 7915 (Endocrine System). DC 7915 covers a benign — non-cancerous — neoplasm in any specified part of the endocrine system. The code states no percentages of its own; its whole entry is the instruction "Rate as residuals of endocrine dysfunction." So the evaluation comes from the endocrine dysfunction the growth leaves behind, not from the tumor's size or from the fact that it is benign. Where a neoplasm of the same system is malignant, the code is DC 7914 instead, which carries its own 100 percent evaluation.
What evidence helps prove Benign Neoplasms of Endocrine System for VA disability?
Strong evidence for a Benign Neoplasms of Endocrine System claim includes: Endocrinologist reports documenting the diagnosis and its hormonal impact; CT or MRI imaging of the affected gland; Hormone test results showing the functional disruption.
What mistakes should veterans avoid when claiming Benign Neoplasms of Endocrine System?
Common pitfalls when filing for Benign Neoplasms of Endocrine System: Submitting the claim without a hormone panel to establish the functional impact; Missing documentation of the actual symptoms experienced, beyond the imaging finding alone.
Official sources
- 38 CFR § 4.119, Schedule of ratings, endocrine system (Diagnostic Code 7915)
Criteria in quotation marks are the regulation’s own words; everything else on this page is Vetrify’s summary of it. The eCFR text is authoritative. See how Vetrify derives its numbers.
How these figures are checked: our methodology and the open dataset.
VA Calc: Disability Pay
Combine your ratings & see monthly pay on your iPhone · Works offline